0
The pneumococcal conjugate vaccine helps protect against mild and severe infections due to the bacteria Streptococcus pneumoniae. This bacteria frequently causes ear infections, meningitis, and pneumonia in children.
See also: Pneumococcal polysaccharide vaccine
InformationThe pneumococcal conjugate vaccine is an inactivated-bacteria vaccine, which means it uses dead bacteria to teach the immune system to recognize and fight active bacteria.
This vaccine effectively prevents childhood illnesses caused by Streptococcus pneumoniae.
WHO SHOULD GET THIS VACCINE
Children should receive four doses of the vaccine, one dose each at the following ages:
- 2 months
- 4 months
- 6 months
- 12 - 15 months
Pneumococcal conjugate vaccine is not the same as the pneumococcal polysaccharide vaccine, which is used in children over age 2 and in adults. For information on that vaccine, see: Pneumococcal polysaccharide vaccine
RISKS AND SIDE EFFECTS
Most people have no or only minor side effects from the pneumococcal conjugate vaccine. Pain and redness at the injection site can occur. As is the case with any drug or vaccine, there is a small risk of an allergic reaction, more serious reactions, or even death.
Watch for and be familiar with how to treat minor side effects such as low-grade fever or tenderness at the injection site.
CONSIDERATIONS
If your child has a fever or an illness that is more serious than a cold, the vaccine may be withheld or delayed.
CALL YOUR HEALTH CARE PROVIDER IF:
Call your health care provider if moderate or serious side effects appear after this vaccine has been given, or if you have any questions or concerns.
Call your health care provider if you are not sure if the pneumococcal conjugate vaccine should be delayed, withheld, or only given to a specific person.
ReferencesAmerican Academy of Pediatrics Committee on Infectious Diseases. Recommended immunization schedules for children and adolescents -- United States, 2008. Pediatrics. 2008;121(1):219-220.
Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 years---United States, 2009. MMWR. January 2, 2009;57(51&52);Q1-Q4.
What else can I help you with?
What form of pneumonia has a vaccine?
Pneumococcal pneumonia, caused by the bacterium Streptococcus pneumoniae, has vaccines available to help prevent infection. There are two main types of pneumococcal vaccines: the pneumococcal conjugate vaccine (PCV13 or PCV15) and the pneumococcal polysaccharide vaccine (PPSV23). These vaccines are recommended for certain populations, including young children, older adults, and individuals with specific health conditions. Vaccination can significantly reduce the risk of severe illness and complications associated with pneumococcal pneumonia.
Can you give flu vaccine and pneumococcal vaccine together?
no
Does medicaid cover pneumonia vaccine in NC?
Yes, Medicaid in North Carolina covers the pneumonia vaccine for eligible beneficiaries. This includes both the pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine (PPSV23). Coverage typically applies to individuals who meet certain age criteria or have specific health conditions. It's best to check with a healthcare provider or Medicaid for the most current information regarding coverage and eligibility.
What is the procedure code for vaccine pneumococcal?
90732
What is meant by the acronym PCV?
The acronym PCV in medicine may stand for packed cell volume, pneumococcal conjugate vaccine, or phenoxymethylpenicillin. In the automotive industry PVC means pressure control valve.
Is PPSV recommended for all children?
Pneumococcal polysaccharide vaccine (PPSV) is generally not recommended for all children. It is primarily indicated for children aged 2 years and older who are at increased risk for pneumococcal disease due to certain medical conditions. The routine vaccination schedule for children typically involves the pneumococcal conjugate vaccine (PCV) instead. Consultation with a healthcare provider is essential to determine the appropriate vaccination based on individual health needs.
How the PVC vaccine made?
The PVC (Pneumococcal Conjugate Vaccine) is made by combining polysaccharides from the capsule of Streptococcus pneumoniae bacteria with a carrier protein. The polysaccharides are purified and then conjugated to the protein, enhancing the immune response. This process stimulates the body to produce antibodies against the bacteria, providing protection against pneumococcal diseases. The vaccine undergoes rigorous testing for safety and efficacy before being approved for public use.
What is cpt code 90714?
CPT code 90714 refers to the administration of the pneumococcal conjugate vaccine (PCV13) for individuals aged 6 weeks through 17 years. This vaccine protects against infections caused by Streptococcus pneumoniae, which can lead to serious conditions such as pneumonia, meningitis, and bloodstream infections. It is commonly used in pediatric immunization schedules to enhance community immunity against pneumococcal diseases.
What is the Difference between haemophilus b meningococcal conjugate and haemophilus B tetanus toxoid conjugate?
One combines the HIB vaccine with meningococcal vaccine, and the other with tetanus vaccine.
What is pneumococcal polysaccharide vaccine?
Pneumococcal polysaccharide disease is caused by a bacteria. It can be deadly but a vaccine was developed to head off the disease before it starts. The vaccine works when a small amount of the bacteria is injected into the patient and his or her immunity works against the disease, causing immunity.
What is the age limit for CPT Code 90687?
CPT Code 90687 refers to the pneumococcal conjugate vaccine (PCV13) for adults. There is no specific age limit associated with this code; however, it is primarily recommended for adults aged 19 years and older, particularly those at increased risk for pneumococcal disease. Always refer to current guidelines for any updates or specific recommendations.
How often should you have pneumonia shot?
The pneumonia vaccine schedule depends on the type of vaccine you receive. For the pneumococcal conjugate vaccine (PCV13), it is recommended for adults aged 65 years or older to receive a single dose. For the pneumococcal polysaccharide vaccine (PPSV23), adults aged 65 or older may need a single dose, with a potential second dose if it has been more than 5 years since the first dose. It is important to consult with a healthcare provider to determine the appropriate vaccination schedule based on individual health factors.
